The HBL-1, HT, TMD8, WSU-DLCL-2 DLBCL cell lines and Karpas-422 NHL cell lines and the Raji Burkitt’s lymphoma cell line all demonstrate phenotypic sensitivity to the GLS inhibitor BPTES (Supplementary Figure 1). Here, GLS is linked to non-Hodgkin lymphoma.